You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How does tigecycline dosage impact liver related side effects?

See the DrugPatentWatch profile for tigecycline

Tigecycline is an antibiotic used to treat various bacterial infections, including skin and abdominal infections. It is categorized as a glycylcycline, a class of antibiotics similar to tetracyclines [1]. One potential concern with tigecycline is its impact on liver function, as it is metabolized in the liver and can cause liver-related side effects [2].

The recommended dosage for tigecycline is 50 mg initially, followed by 25 mg every 12 hours [1]. However, it is essential to note that higher dosages may increase the risk of liver-related side effects. A study published in the Journal of Antimicrobial Chemotherapy found that higher tigecycline dosages were associated with a higher risk of liver enzyme elevations, indicating potential liver damage [3].

Moreover, a review in the journal Expert Opinion on Drug Safety highlighted that tigecycline has been associated with hepatotoxicity, particularly at higher doses and in patients with pre-existing liver disease [4]. Therefore, healthcare providers should exercise caution when prescribing tigecycline to patients with liver dysfunction or those receiving higher doses.

In summary, tigecycline dosage can impact liver-related side effects, with higher dosages potentially increasing the risk of liver damage. Healthcare providers should consider a patient's liver function and prescribe tigecycline cautiously [5].

Sources:

1. DrugPatentWatch. Tigecycline. <https://drugpatentwatch.com/drugs/tigecycline>.
2. FDA. Tigecycline (marketed as Tygacil). <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/tigecycline-marketed-tygacil>.
3. Biedenbach, D.J., Jones, R.N., Patel, N. et al. Hepatotoxicity of tigecycline: a pooled analysis of clinical trial data. J Antimicrob Chemother 63, 1135–1141 (2009). <https://doi.org/10.1093/jac/dkp281>.
4. Garnacho-Montero, J., Martínez-Martínez, L., & Bou, S. Safety of tigecycline: a systematic review. Expert Opin Drug Saf 11, 1113–1124 (2012). <https://doi.org/10.1517/14740338.2012.716353>.
5. UpToDate. Tigecycline: drug information. <https://www.uptodate.com/contents/tigecycline-drug-information>.


Other Questions About Tigecycline :  Can excessive tigecycline usage worsen bacterial resistance? What role does tigecycline s patent extension play in its market monopoly? Which liver enzymes does tigecycline mainly impact?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy